Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions
The results of the clinico-microbiological investigation of the levofloxacin efficacy in the treatment of 38 patients with respiratory infections or various pyo-inflammatory lesions are presented. The positive results were stated in 29 (76.3%) patients. No adverse reactions were observed.
Saved in:
| Main Authors: | V. I. Sokolova, D. A. Sychev, M. B. Babarina, D. A. Zaikov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/578 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Levofloxacin. Expediency of High-Dose Regimens in Therapy of Lower Respiratory Tract Infections
by: I. A. Guchev, et al.
Published: (2020-05-01) -
Levofloxacin (Tavanic) in Complex Therapy of Tuberculosis
by: G. B. Sokolova, et al.
Published: (2020-05-01) -
First‐Line Levofloxacin‐Based Triple Therapy Versus Standard Bismuth‐Based Quadruple Therapy for Helicobacter pylori Eradication in Saudi Arabia: A Retrospective Single‐Center Study
by: Abdulrhman Khaled Al Abdulqader, et al.
Published: (2025-02-01) -
Novel Levofloxacin Derivatives as Potent Antibacterial Agents
by: Moshafi M. H., et al.
Published: (2017-04-01) -
Synthesis a Number of Heterocyclic Compounds Derived From Levofloxacin
by: Ekram Abdullah Basheer, et al.
Published: (2023-02-01)